It is a chemicals public limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | Struck OffKratos Pharmaceuticals Limited, a struck off public limited company, was established on 16 May 2011 in Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2011PLC217498. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Irfan Ahmed Khan (Director), Nikhil Ratilal Shah (Director), Rajesh Raghunath Pawar (Director). Past directors included Darayus Kersasp Paowalla, Rajesh Raghunath Pawar. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 317, Maker Chambers V 221, Nariman Point, Mumbai, Maharashtra, 400021.
U24100MH2011PLC217498
217498
16 May 2011
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Kratos Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Irfan Ahmed Khan | Director | 16 May 2011 | Current |
| Nikhil Ratilal Shah | Director | 16 May 2011 | Current |
| Rajesh Raghunath Pawar | Director | 25 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Apr 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Kratos Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Kratos Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kratos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kratos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kratos Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kratos Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.
Progress on Rajesh Raghunath Pawar was appointed as a Director was appointed as a Director on 25 Apr 2013 & has been associated with this company since 12 years 7 months . was documented.
The activity Kratos Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was completed.
Irfan Ahmed Khan was appointed as a Director was appointed as a Director on 16 May 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.
Nikhil Ratilal Shah was appointed as a Director was appointed as a Director on 16 May 2011 & has been associated with this company since 14 years 6 months . was recorded as a recent event.
Progress on Kratos Pharmaceuticals Limited was registered on 16 May 2011 with Roc Mumbai & aged 14 years 6 months as per MCA records. was documented.
The CIN of Kratos Pharmaceuticals Limited is U24100MH2011PLC217498.
Kratos Pharmaceuticals Limited is headquartered at 317, Maker Chambers V 221, Nariman Point, Mumbai, Maharashtra, 400021.
Kratos Pharmaceuticals Limited was incorporated on 16 May 2011.
The current directors of Kratos Pharmaceuticals Limited are
The primary industry of Kratos Pharmaceuticals Limited is Chemicals.
Kratos Pharmaceuticals Limited is unlisted.
The authorized capital of Kratos Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX